Vitamin K anticoagulants are used to treat and prevent the formation of blood clots and to prevent blood clotting in the blood vessels. Here is some information about the use of vitamin K antagonist anticoagulants.

Cammic contains the active ingredient tranexamic acid, which is an anticoagulant drug. Cammic 500 mg medicine contains tranexamic acid along with some other active ingredients with a sufficient amount of 1 tablet. Let's find out what Cammic tablets are and how to use them?

Enoxaparin 60mg is used to prevent the effects of blood clots on the body. Therefore, the drug is used in cases where there is a high risk of blood clot formation.

An embolism is caused by a blood clot inside a blood vessel. What is a blood clot? It's a clump of cells and proteins in the blood that normally stops bleeding during an injury and disappears as the wound heals. If these clots form abnormally, when they are not needed, they can block or completely block a blood vessel.

Daily use of the anticoagulant Warfarin (Coumadin®, Zofarin®) or Acenocoumaron (Sintrom®, Mini-sintrom®) is essential for your condition. When using the medication, please note the following:

Coagulation is a change in the physical state of blood, an important physiological process that occurs in the human body. Without the clotting process, the human body will die early due to blood loss. Coagulation tests play an extremely important role in detecting, diagnosing and treating blood clotting disorders in patients.

Blood clotting is one of the extremely important physiological processes in the normal human body, in case the body is damaged and leads to bleeding. The blood clotting test will help check the ability of blood clotting to have timely treatment.

Blood clots are the result of a series of events that occur during the hemostasis process, including vasoconstriction, platelet aggregation, and coagulation. This can cause angina, myocardial infarction, stroke, or venous thromboembolism, leaving serious consequences. The use of anticoagulants plays an important role in the prevention and treatment of diseases caused by thrombosis.

It is estimated that about 20% to 40% of patients with atrial fibrillation have concomitant coronary artery disease (CAD), a sizable proportion of which require revascularization with percutaneous coronary intervention (PCI). and stenting. Such patients require dual antiplatelet therapy (DAPT) to prevent the risk of stent thrombosis and additional thrombotic ischemic events. Read more to understand more about anticoagulation in atrial fibrillation after percutaneous coronary intervention.